Inogen (INGN) Other financing activities (2013 - 2026)
Inogen's (INGN) quarterly Other financing activities came in at $373000.0 in Q1 2026, down 23.72% year-on-year from $489000.0 in Q1 2025, and down 22.61% on a QoQ basis from $482000.0 in Q3 2025.
Inogen (INGN) Other financing activities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Other financing activities data on file, last reported at $373000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 23.72% year-over-year to $373000.0 in Q1 2026; TTM through Mar 2026 was $855000.0, a 8.06% decrease from a year earlier, with the FY2025 full-year figure at $971000.0, up 19.73% from the prior year.
- Other financing activities for Q1 2026 stood at $373000.0, down from $482000.0 in the prior quarter.
- Over the last five years, Other financing activities for INGN reached as high as $1.7 million in Q3 2022 and fell as low as -$1.6 million in Q4 2022.
- Historically, Other financing activities has averaged $299363.6 across 5 years, with a median of $384000.0 in 2023.
- Across the five-year window, Other financing activities tumbled 99.25% in 2022 and soared 1224.14% in 2023, its largest moves.
- Year by year, Other financing activities stood at -$1.6 million in 2022, then jumped by 143.11% to $710000.0 in 2023, then tumbled by 37.89% to $441000.0 in 2024, then climbed by 9.3% to $482000.0 in 2025, then declined by 22.61% to $373000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $373000.0 in Q1 2026, $482000.0 in Q3 2025, and $489000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 373,000.00 |
| Mar 31, 2026 | 373,000.00 |
| Sep 30, 2025 | 482,000.00 |
| Sep 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 489,000.00 |
| Mar 31, 2025 | 489,000.00 |
| Sep 30, 2024 | 441,000.00 |
| Sep 30, 2024 | 441,000.00 |
| Mar 31, 2024 | 370,000.00 |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 710,000.00 |
| Dec 31, 2023 | 710,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | -1.65 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Jun 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |